Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
42 hedge funds and large institutions have $23M invested in Vaxart in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
26% more capital invested
Capital invested by funds: $18.3M → $23M (+$4.72M)
11% more funds holding
Funds holding: 38 → 42 (+4)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $105K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$4.52M |
| 2 |
BlackRock
New York
|
+$532K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$500K |
| 4 |
DD
Dominick & Dominick
New York
|
+$104K |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$93.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$532K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$272K |
| 3 |
RCM
Ratan Capital Management
Miami Beach,
Florida
|
-$189K |
| 4 |
Goldman Sachs
New York
|
-$157K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$129K |
VXRT Hedge Fund Activity: Q4 2013 in Review
42 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2013, worth a combined $23M — up 26% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VXRT positions and 3 closed out — a net gain of 5 holders — while 11 added to existing stakes and 13 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $4.52M. The largest seller was BlackRock Advisors, cutting an estimated $532K.
- 42 institutional investors held Vaxart (VXRT) as of Q4 2013, up from 38 in Q3 2013.
- Funds reported $23M of Vaxart stock for Q4 2013, up 26% quarter-over-quarter.
- 8 funds opened new Vaxart positions in Q4 2013 and 3 closed out, a net change of +5 holders.
- The largest Vaxart buyer in Q4 2013 was Baker Bros. Advisors, an estimated $4.52M added.
- The largest Vaxart seller in Q4 2013 was BlackRock Advisors, an estimated $532K sold.
Based on aggregated 13F filings for Q4 2013.